Bank of America Cuts Neumora Therapeutics (NASDAQ:NMRA) Price Target to $7.00
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by Bank of America from $22.00 to $7.00 in a report released on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other equities research analysts have also commented on the company. JPMorgan Chase & Co. lowered Neumora Therapeutics from an […]
More Stories
US Considering Use of ‘Mother of All Bombs’ Against Iran
By Jack Phillips U.S. President Donald Trump on Thursday said his administration would not use nuclear weapons against Iran, following...
How to Enhance Video Quality for YouTube Beginners
YouTube has no shortage of great ideas. What separates one channel from another is often how those ideas look on...
DOJ Sues California After Flagging 20,000 ‘Likely Noncitizens’ Registered to Vote
By Jill McLaughlin The Department of Justice (DOJ) filed a lawsuit against California on Oct. 15 over its voter list...
Ukraine Resumes Strikes on Russian Refineries as Zelenskyy Says ‘We’re Done’ With Trump’s Energy Truce
By Guy Birchall Ukraine has resumed attacks on Russian refineries after Ukrainian President Volodymyr Zelenskyy said Kyiv was “done” complying...
Musk Says US Government Is Controlling Starshield Services Amid Reported Disruptions in Ukraine
By Ryan Morgan SpaceX CEO Elon Musk denied reports that the company curbed its military-oriented Starshield satellite internet service in...
2027 Social Security Payment Boost Announced: 4 Things to Know
By Jack Phillips Social Security officials on Wednesday announced the largest cost-of-living adjustment (COLA) for retired beneficiaries in four years,...